96 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
transferred to the customer. For collaborative arrangements that fall within the scope of IFRS 15, the Company applies the revenue recognition model to part … in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
transferred to the customer. For collaborative arrangements that fall within the scope of IFRS 15, the Company applies the revenue recognition model … )
(Unaudited)
11. Financial Instruments and Risk Management - continued
Credit risk is the risk of an unexpected loss if a customer or counterparty
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
for the goods and services transferred to the customer. For collaborative arrangements that fall within the scope of IFRS 15, the Company applies … and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
that it is entitled to in exchange for the goods and services transferred to the customer. For collaborative arrangements that fall within the scope of IFRS … )(Unaudited)
11. Financial Instruments and Risk Management - continued
Credit risk is the risk of an unexpected loss if a customer or counterparty fails
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
the consideration that it is entitled to in exchange for the goods and services transferred to the customer. For collaborative arrangements that fall … if a customer or counterparty fails to meet its contractual obligations. The Company's credit risk is primarily attributable to its cash and cash equivalents
6-K
EX-99.2
s7xqt56
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.2
jfeb530tjml nw
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
06xfjz 657x095afa
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
3sbszyjysco 8ua
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
80pelhnu
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
d1fqy 3nmuvg2beo5
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.4
tcwpz
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
8ovxhkpw1dharbokk
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
4k0er
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
vvuzxjtpi5qti9ia7 ee
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
b7v 6wvz6fuqxo
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
n0npap8m867
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
03l oil52
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm